• Cryptomonnaies
  • Marchés de Prédiction
  • Actualités
  • Trading Agentique
  • Articles
  • Ligues

Rechercher des Cryptomonnaies

Cryptomonnaies en tendance

CoinRithm

Entreprise

Entité légale
Bees-x Limited
Numéro de société
13308136
Constituée en
England and Wales
Siège social
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm est un service d'information et de recherche exploité par Bees-x Limited. Il n'est pas autorisé par la Financial Conduct Authority (FCA) à exercer des activités réglementées, et rien sur ce site ne constitue un conseil financier.

Explorer

CryptomonnaiesMarchés de PrédictionActualitésArticlesAgent ArenaLigues

Fonctionnalités

Tableau de bordÉchange FictifTrading AgentiquePortefeuilleListe de suiviParamètres

Entreprise

À Propos de NousMethodologieConditions d'utilisationPolitique de ConfidentialitéPolitique en Matière de CookiesAvertissement

Support

Contactez le SupportFAQKit développeurDocs MCP

Réseaux

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Tous droits réservés.
Disponible sur Google PlayTélécharger sur l'App Store
  • Accueil
  • MarchésMarchés de Prédiction
  • Actualités
  • Tableau de bord
  1. Marchés de Prédiction
  2. Health & Medicine
  3. Will the FDA approve retatrutide?
Will the FDA approve retatrutide?

Will the FDA approve retatrutide?

11.0% (24h)Health & MedicineOne-Off6mo
KalshiKalshiVérifier la disponibilitéKYC requis2% de frais
Probabilité implicite actuelle
Before Jan 1, 2027
Before Jan 1, 2027 17%-11.0%
En tête parmi 5 options
Qualite du marche

28 / 100

Faible qualité
Volume 24h

5,1 €

Liquidité

73,8 €

Faible liquidité
Achat / Vente

16.0% / 19.0%

Spread

18.8%

Spread large
Données du marché

Mis à jour il y a 7 minutes

14 mai 26, 2:001 janv. 27, 4:59

Tendances

Résultat24hProbabilité

Résultat choisi

Before Jan 1, 202717%

PolymarketÉgalement disponible sur Polymarket

FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

1.0%6mo
Oui
Oui
-0.0%12%
Non
Non
+0.0%89%
52 • Qualité moyenneSpread largeLiquidité moyenne
Volume total493,2 k €
Volume 24h238,8 €
PolymarketPOLYMARKET

Règles

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2027, then the market resolves to Yes.

Kalshi
  • An approval is defined as:
  • For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA (sNDA) or supplemental BLA (sBLA) for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Application (ANDA) For biosimilars: FDA approval of a 351(k) application
  • The following constitute approvals that trigger the Payout Criterion:
  • Standard approval (traditional approval based on clinical benefit) Accelerated approval (based on surrogate endpoints) Approval with Risk Evaluation and Mitigation Strategy (REMS) Approval with restricted distribution or indication limitations, except compassionate use/expanded access programs
  • The following do NOT constitute approvals:

Les probabilités peuvent varier en raison de structures de marché, frais et bassins de participants différents.

Marchés Associés

Hantavirus pandemic in 2026?

Hantavirus pandemic in 2026?

145,3 k €
Oui: 5%PolymarketPOLYMARKET
New pandemic in 2026?

New pandemic in 2026?

16,6 k €
Oui: 10%PolymarketPOLYMARKET
Manifold Markets

How many movies will gross >$1 billion in 2026?

1,3 k €
0-3: 5.7%Manifold MarketsMANIFOLD MARKETS
Manifold Markets

Which disease will be eradicated next in humans?

462,5 €
Polio: 26.7%Manifold MarketsMANIFOLD MARKETS
When, where or how will Trump die?

When, where or how will Trump die?

137,8 €
2025: 0%Manifold MarketsMANIFOLD MARKETS

Actifs dans ces sujets

BitcoinBTC$62,915.76+2.84%EthereumETH$1,659.26+2.18%SolanaSOL$65.38+2.34%DogecoinDOGE$0.0851+2.03%XRPXRP$1.12+1.00%BNBBNB$596.96+2.12%

Actualités Associées

Chainalysis reveals $100 million peptide market built on cryptoCrypto NewsGray peptide vendors embrace stablecoins as safety fears deepenCrypto NewsOpenAI Expands GPT-Rosalind Access with Rosalind BiodefenseBlockchain.NewsOpenAI Expands GPT-Rosalind Capabilities for Life SciencesBlockchain.NewsBrian Armstrong’s NewLimit Raises $435M for Human TrialsCrypto News

Règles

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2027, then the market resolves to Yes.

Kalshi
  • An approval is defined as:
  • For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA (sNDA) or supplemental BLA (sBLA) for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Application (ANDA) For biosimilars: FDA approval of a 351(k) application
  • The following constitute approvals that trigger the Payout Criterion:
  • Standard approval (traditional approval based on clinical benefit) Accelerated approval (based on surrogate endpoints) Approval with Risk Evaluation and Mitigation Strategy (REMS) Approval with restricted distribution or indication limitations, except compassionate use/expanded access programs
  • The following do NOT constitute approvals: